Moore David Scott
- SEC CIK
- 0002088466
In the past year, 1 open-market purchase filing worth $250.2K and no sales.
Current role at each company
- CRVS Corvus Pharmaceuticals, Inc.Directoras of Jun 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $250.2K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$250.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Moore David Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Moore David ScottDirector | PPurchase | +21.7K | $11.53 | +$250.2K | New position21.7K after |